GeneDx Holdings Corp. Finite-Lived Intangible Asset, Expected Amortization, Year Four
GeneDx Holdings Corp. (WGS) had Finite-Lived Intangible Asset, Expected Amortization, Year Four of $16.42 million as of 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Notes › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour · last filed 2026-02-23
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Four $16.42M.
- 2024-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Four $14.03M.
- 2023-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Four $14.03M.
- 2023-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year Four $14.03M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Four |
|---|---|
| 2025-12-31 | $16.42M 10-K · filed 2026-02-23 |
| 2024-12-31 | $14.03M 10-K · filed 2025-02-20 |
| 2023-12-31 | $14.03M 10-K · filed 2024-02-23 |
| 2023-06-30 | $14.03M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $14.03M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $14.03M 10-K · filed 2023-03-16 |
| 2022-09-30 | $14.03M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $14.03M 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |